[
    "{\"step_by_step_thinking\": \"To determine if Tilavonemab is effective for progressive supranuclear palsy, we need to review the available evidence. Tilavonemab is a monoclonal antibody that targets the tau protein, which is believed to play a role in the development of progressive supranuclear palsy. To determine its effectiveness, we need to look at clinical trials or studies that have specifically evaluated Tilavonemab in patients with progressive supranuclear palsy.\", \"answer_choice\": \"B. no\"}"
]